Cytocell Limited – Trademark Portfolio
Entity Type: 03
Cytocell Limited holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CYTOCELL and MYPROBES. The owner is based in Cambridge.
418 Cambridge Science Park, Milton Road
Cambridge CB40PZ , GB
Showing of trademarks Trademarks
Trademark Classifications
Cytocell Limited's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Cytocell Limited have?
Cytocell Limited has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.
What trademark classes does Cytocell Limited file in?
Cytocell Limited files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cytocell Limited's most well-known trademarks?
Cytocell Limited's registered trademark portfolio includes well-known marks such as CYTOCELL and MYPROBES. These are among 2 currently registered trademarks in the portfolio.
What is Cytocell Limited's trademark registration success rate?
Cytocell Limited has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.